Integer Holdings Co. (NYSE:ITGR) is Tributary Capital Management LLC's Largest Position

Tributary Capital Management LLC boosted its position in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) by 0.8% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 287,525 shares of the medical equipment provider's stock after purchasing an additional 2,289 shares during the quarter. Integer comprises about 2.9% of Tributary Capital Management LLC's holdings, making the stock its biggest holding. Tributary Capital Management LLC owned 0.86% of Integer worth $38,103,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Loomis Sayles & Co. L P boosted its holdings in Integer by 3.0% in the third quarter. Loomis Sayles & Co. L P now owns 538,027 shares of the medical equipment provider's stock worth $69,943,000 after purchasing an additional 15,446 shares during the last quarter. Jane Street Group LLC raised its position in shares of Integer by 23.3% during the 3rd quarter. Jane Street Group LLC now owns 151,397 shares of the medical equipment provider's stock valued at $19,682,000 after purchasing an additional 28,572 shares during the period. Verition Fund Management LLC increased its stake in Integer by 17.4% in the 3rd quarter. Verition Fund Management LLC now owns 3,470 shares of the medical equipment provider's stock worth $451,000 after buying an additional 515 shares in the last quarter. Versant Capital Management Inc raised its holdings in Integer by 98.4% during the fourth quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider's stock valued at $49,000 after acquiring an additional 183 shares during the period. Finally, Lord Abbett & CO. LLC boosted its stake in shares of Integer by 3.5% in the third quarter. Lord Abbett & CO. LLC now owns 290,120 shares of the medical equipment provider's stock worth $37,716,000 after acquiring an additional 9,754 shares during the period. 99.29% of the stock is currently owned by institutional investors.

Integer Trading Down 0.3 %

ITGR stock traded down $0.49 during mid-day trading on Friday, reaching $142.79. 184,834 shares of the stock traded hands, compared to its average volume of 150,117. The business has a 50-day moving average price of $137.11 and a two-hundred day moving average price of $129.61. The stock has a market capitalization of $4.79 billion, a PE ratio of 44.07, a PEG ratio of 1.80 and a beta of 1.12. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28. Integer Holdings Co. has a one year low of $94.56 and a one year high of $144.22.

Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.07. Integer had a net margin of 6.70% and a return on equity of 11.63%. The business had revenue of $431.42 million during the quarter, compared to the consensus estimate of $440.59 million. During the same quarter last year, the firm earned $1.27 earnings per share. The firm's quarterly revenue was up 8.7% compared to the same quarter last year. Equities research analysts expect that Integer Holdings Co. will post 5.33 EPS for the current year.

Wall Street Analysts Forecast Growth

ITGR has been the topic of a number of research analyst reports. Truist Financial boosted their price target on Integer from $147.00 to $163.00 and gave the stock a "buy" rating in a report on Wednesday, December 11th. Piper Sandler restated an "overweight" rating and set a $140.00 target price (up previously from $125.00) on shares of Integer in a research report on Friday, October 25th. Wells Fargo & Company reaffirmed an "overweight" rating and set a $160.00 target price on shares of Integer in a research note on Tuesday, December 3rd. Citigroup boosted their price target on shares of Integer from $130.00 to $145.00 and gave the stock a "neutral" rating in a research note on Wednesday, December 11th. Finally, Bank of America raised their price objective on Integer from $135.00 to $145.00 and gave the company a "buy" rating in a research report on Tuesday, October 1st. One analyst has rated the stock with a hold rating and eight have given a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $146.56.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.